The FDA granted priority review for Datroway based on results from the TROPION-Breast02 Phase III trial.

May 2026Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor ...

May 2026Camizestrant in combination with a CDK4/6 inhibitor recommended for approval in the EU by CHMP for 1st-line advanced ER-positive breast cancer Recommendation based on SERENA-6 Phase III trial ...

AstraZeneca's Oncology and Rare Disease segments delivered 16% and 15% growth, powered by IMFINZI and ULTOMIRIS, respectively ...

The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term ...

By Bhanvi Satija LONDON, May 18 (Reuters) - Anglo-Swedish drugmaker AstraZeneca said on Monday its hypertension pill ...

Sir Kier Starmer announces the multi-million-pound investment in the House of Commons.

A ‌European Medicines ​Agency committee said ‌on ⁠Friday it ⁠has ​adopted ​a ​positive ‌opinion of AstraZeneca’s experimental ...

(Reuters) -AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat a type of lung cancer, marking the first approval of the therapy ...

Sir Pascal Soriot is one of the most consequential pharmaceutical executives in history. He is a French-born Australian businessman who took over a British-Swedish pharma giant in crisis, rebuilt it ...

After an impressive phase 3 showing last fall, AstraZeneca’s wager on CinCor Pharma and its aldosterone synthase inhibitor ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...